Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Harry Southworth"'
Autor:
Jeffrey A Cohen, Giancarlo Comi, Ludwig Kappos, Sarah Harris, Lawrence Steinman, Bruce AC Cree, James K Sheffield, Harry Southworth
Publikováno v:
BMJ Neurology Open, Vol 3, Iss Suppl 1 (2021)
Externí odkaz:
https://doaj.org/article/829013cee00b44a8810698fa57078978
Autor:
Daniela K Schlüter, Lucy Spain, Wei Quan, Harry Southworth, Nicola Platt, Joe Mercer, Lik-Kwan Shark, John C Waterton, Mike Bowes, Peter J Diggle, Mandy Dixon, Jane Huddleston, John Goodacre
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0223711 (2019)
Our objective was to determine the efficacy and feasibility of a new approach for identifying candidate biomarkers for knee osteoarthritis (OA), based on selecting promising candidates from a range of high-frequency acoustic emission (AE) measurement
Externí odkaz:
https://doaj.org/article/a026fa9c69a74c0eb837bf05ac7a23fc
Autor:
Sarah Harris, Patrick Vermersch, Xavier Montalban, Hans-Peter Hartung, Ludwig Kappos, Harry Southworth, James K. Sheffield, Diego Silva, Jeffrey A. Cohen
Publikováno v:
Sunday, April 23.
Autor:
Harry Southworth, Jeffrey A. Cohen, Giancarlo Comi, Sarah Harris, Bruce A.C. Cree, James K Sheffield, Lawrence Steinman, Ludwig Kappos
Publikováno v:
BMJ Neurology Open, Vol 3, Iss Suppl 1 (2021)
Autor:
Sarah Harris, Ludwig Kappos, Lawrence Steinman, Giancarlo Comi, Jeffrey A. Cohen, Bruce A.C. Cree, ozanimod study investigators, Douglas L. Arnold, James K Sheffield, Harry Southworth
Publikováno v:
European journal of neurology, vol 28, iss 11
Background and purposeWe investigated plasma neurofilament light chain concentration (pNfL) as a biomarker for neuroaxonal damage and disease activity using data from Phase 3 trials of ozanimod in relapsing multiple sclerosis (RMS).MethodspNfL was me
Autor:
Collin M. Spencer, Scott S. Zamvil, Sarah Harris, Bruce A.C. Cree, Harry Southworth, Jonathan Q. Tran
Publikováno v:
Neurology(R) neuroimmunology & neuroinflammation, vol 7, iss 5
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
ObjectiveTo better understand ozanimod's mechanism of action (MOA), we conducted exploratory analyses from a phase 1 study to characterize ozanimod's effect on circulating leukocyte subsets in patients with relapsing multiple sclerosis.MethodsAn open
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddc58a78e791dba48d7de361bb5fcd24
https://escholarship.org/uc/item/30q8j3v1
https://escholarship.org/uc/item/30q8j3v1
Autor:
Mandy Dixon, Lucy Spain, Lik-Kwan Shark, Harry Southworth, Michael J. Bowes, John Goodacre, Nicola Platt, Jane Huddleston, John C. Waterton, Daniela K Schlüter, Joe Mercer, Peter J. Diggle, Wei Quan
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 10, p e0223711 (2019)
PLOS ONE
PLoS ONE, Vol 14, Iss 10, p e0223711 (2019)
PLOS ONE
Our objective was to determine the efficacy and feasibility of a new approach for identifying candidate biomarkers for knee osteoarthritis (OA), based on selecting promising candidates from a range of high-frequency acoustic emission (AE) measurement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17b046abb20055a62ec7648113cf49e7
https://insight.cumbria.ac.uk/id/eprint/5171/1/pone.0223711.pdf
https://insight.cumbria.ac.uk/id/eprint/5171/1/pone.0223711.pdf
Autor:
Sarah Harris, Harry Southworth, Geert R. D'Haens, Douglas C. Wolf, Brian G. Feagan, Stephen B. Hanauer, Subrata Ghosh, William J. Sandborn, Severine Vermeire
Publikováno v:
Gastroenterology. 160:S8-S9
Autor:
Marion Vancassel, Jonathan Q. Tran, Sarah Harris, Bruce A.C. Cree, Harry Southworth, Collin M. Spencer, Scott S. Zamvil
Publikováno v:
Revue Neurologique. 177:S109
Introduction Ozanimod, modulateur des recepteurs de la sphingosine-1-phosphate de sous-types 1 et 5, entraine la sequestration des lymphocytes dans les tissus lymphoides, reduisant le nombre de lymphocytes dans le sang peripherique. Objectifs Caracte
Statistical Analysis of Cumulative Serious Adverse Event Data From Development Safety Update Reports
Autor:
Harry Southworth, Brian Davis
Publikováno v:
Therapeutic innovationregulatory science. 50(2)
Monitoring safety in clinical trials by regulatory authorities and sponsors involves the clinical review, often subjectively, of large data sets of different types of safety information which may require considerable resources.This study investigated